arrow_back Back to App

Individual Drug Review for Medicare Coverage

This act changes how Medicare evaluates drugs and treatments. Instead of reviewing entire classes of drugs, Medicare will now assess each drug individually, potentially affecting the availability and coverage of specific therapies for patients.
Key points
Medicare will review drugs individually, not by class, which may alter coverage rules.
This change applies to drugs and therapies used in Medicare-funded research.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_9127
Sponsor: Rep. Buchanan, Vern [R-FL-16]
Process start date: 2022-10-04